By Counterforce Health Team in Emgality (galcanezumab-gnlm) —

How to Get Emgality (galcanezumab-gnlm) Covered by UnitedHealthcare in Pennsylvania: Complete Prior Authorization Guide 2025

Answer Box: Getting Emgality Covered by UnitedHealthcare in Pennsylvania

Emgality (galcanezumab-gnlm) requires prior authorization from UnitedHealthcare in Pennsylvania. To get approved, you need documented failure of at least two migraine preventives (like topiramate and propranolol) and ≥4 migraine days per month. If denied, Pennsylvania's external review program overturns roughly 50% of appeals. Start today: Have your neurologist submit a PA through the UHC Provider Portal with your migraine diary and treatment history. If denied, you have 180 days to appeal internally, then 4 months for external review through Pennsylvania's binding process.

Table of Contents

Is Emgality Covered by UnitedHealthcare?

UnitedHealthcare covers Emgality (galcanezumab-gnlm) on most commercial plans, but prior authorization is required along with step therapy and quantity limits. The medication is typically classified as a specialty drug requiring OptumRx specialty pharmacy dispensing.

Coverage at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Doctor must get approval before filling UHC Provider Portal UHC CGRP Policy
Step Therapy Must try 2+ preventives first Same policy document UHC Step Therapy
Specialty Pharmacy Must use OptumRx/Optum Specialty Member portal drug lookup UHC PDL
Age Requirement Adults only (≥18 years) PA policy Same as above
Quantity Limits 120mg monthly after loading dose Quantity limits list UHC Quantity Limits

Prior Authorization Process

Who Submits the Prior Authorization?

Your prescribing physician (typically a neurologist or headache specialist) must submit the PA request through UnitedHealthcare's electronic system. You cannot submit it yourself.

Step-by-Step: Fastest Path to Approval

  1. Gather Documentation (Patient): Compile your migraine diary showing frequency over 3+ months and complete list of failed preventive medications with dates, doses, and reasons for stopping.
  2. Schedule Appointment (Patient): Meet with your neurologist to review your treatment history and discuss Emgality as an option.
  3. Submit PA Request (Doctor): Your physician submits the PA through the UHC Provider Portal with attached clinical documentation.
  4. Decision Timeline (UHC): Non-urgent requests decided within 72 hours; urgent requests within 24 hours of complete submission.
  5. Approval Processing (OptumRx): If approved, prescription is transferred to Optum Specialty Pharmacy for fulfillment.
  6. Home Delivery (Patient): Coordinate shipping address and payment method with OptumRx for monthly deliveries.
  7. Monitor Response (Patient/Doctor): Track migraine frequency for renewal documentation at 11 months.
Tip: Electronic PA submission is now required for most UHC commercial plans as of 2025. Fax submissions may cause delays.

Timeline and Urgency

Standard Processing Times

  • Non-urgent PA: Decision within 72 hours of complete submission
  • Urgent PA: Decision within 24 hours when medical urgency is documented
  • Missing information: UHC may request additional documentation, extending timeline by 5-10 business days

When to Request Expedited Review

Your doctor can request urgent processing if:

  • Current migraine frequency is severely impacting work/school
  • Emergency department visits due to migraine
  • Failure of multiple preventives with worsening symptoms

Medical Necessity Criteria

UnitedHealthcare requires specific documentation to approve Emgality for migraine prevention.

Required Clinical Documentation

Diagnosis Requirements:

  • ICHD-3 compliant migraine diagnosis (episodic or chronic)
  • Appropriate ICD-10 code (G43.x series)

Frequency Thresholds (choose one):

  • 4-7 migraine days/month AND <15 total headache days/month, OR
  • ≥8 migraine days/month (any total headache days)
  • Provider attestation that migraine is the predominant headache type

Step Therapy Requirements:

  • Documented failure, intolerance, or contraindication to at least 2 preventive medications from different classes
  • Each trial must be ≥2 months duration (≥30 days in some states)
  • Acceptable preventives include:
    • Topiramate or other antiepileptics
    • Propranolol or other beta-blockers
    • Tricyclic antidepressants (amitriptyline)
    • Valproate

Clinician Corner: Medical Necessity Letter Checklist

Your neurologist should include:

  • Problem Statement: "Patient has [episodic/chronic] migraine with X migraine days and Y total headache days per month, significantly impacting daily function."
  • Prior Treatment History: Detailed table showing drug name, dose, duration, and specific reason for discontinuation for each preventive tried.
  • Clinical Rationale: "Emgality is FDA-approved for migraine prevention and recommended by American Headache Society guidelines after failure of conventional preventives."
  • Supporting Evidence: Reference to attached migraine diary covering 3+ months and any disability scores (MIDAS, HIT-6).
Note: UnitedHealthcare may approve based on claims history and diagnosis codes alone in some cases, but comprehensive documentation improves approval odds.

Understanding Costs

Insurance Coverage Tiers

Emgality is typically placed on Tier 3 or 4 (specialty tier) with higher cost-sharing. Your exact copay depends on your specific plan design.

Manufacturer Savings Program

The Emgality Savings & Support program offers:

  • Commercial insurance patients: As low as $35 per month (if covered)
  • Uninsured patients: As low as $0 for first month, then reduced pricing
  • Restrictions: Cannot be used with Medicare, Medicaid, or other government programs
  • Expiration: Current program expires 12/31/2025

Checking Your Out-of-Pocket Costs

  1. Log into your UHC member portal
  2. Navigate to "Pharmacy" → "Drug Pricing"
  3. Search for "Emgality" to see estimated costs based on your benefit design

Denials and Appeals

Common Denial Reasons & Solutions

Denial Reason How to Overturn Required Documentation
Insufficient migraine frequency documentation Submit detailed migraine diary 3+ months of daily headache tracking
Inadequate step therapy trials Provide complete medication history Pharmacy records, chart notes with dates/doses
Missing medical necessity justification Neurologist submits detailed letter Functional impact, disability scores, work/school absences
Concurrent CGRP use Discontinue other CGRP medications Updated medication list, provider attestation

Pennsylvania Appeals Process

Internal Appeals (Required First Step):

  • Deadline: 180 days from denial notice
  • Submission: UHC member portal, phone, or mail
  • Decision time: 30 days (72 hours for urgent)
  • Required: Copy of denial letter, supporting medical records

Pennsylvania External Review: Pennsylvania launched its Independent External Review Program in January 2024, offering significant patient protections.

  • Eligibility: Must complete internal appeals and receive Final Adverse Benefit Determination
  • Success rate: Approximately 50% of denials overturned in first year
  • Deadline: 4 months from Final Adverse Benefit Determination
  • Submission: Pennsylvania Insurance Department portal or mail
  • Decision time: 45 days standard, 72 hours expedited
  • Cost: No fee to patient
  • Binding: Decision is final and binding on UnitedHealthcare
From our advocates: We've seen Pennsylvania external reviews succeed when patients submit comprehensive medical records within the 15-day evidence window after filing. The independent review organizations often overturn denials when step therapy is well-documented but the insurer missed contraindications or functional impact evidence.

Appeals Scripts

Patient Phone Script for UHC: "I'm calling to file an internal appeal for a denied prior authorization for Emgality. My member ID is [number]. The denial was dated [date] and referenced [denial reason]. I'd like to submit additional medical records and request a peer-to-peer review between my neurologist and your medical director."

Clinic Script for Peer-to-Peer: "This is Dr. [Name] requesting a peer-to-peer review for [patient name], member ID [number], regarding denied Emgality prior authorization. The patient meets all clinical criteria with documented failure of topiramate and propranolol, plus 8+ migraine days monthly. When can we schedule the clinical discussion?"

Renewal Requirements

UnitedHealthcare typically approves Emgality for 12-month periods. Renewal requires:

Documentation for Reauthorization

  • Response to therapy: Documented reduction in migraine frequency and/or intensity
  • Updated migraine diary: Comparison of baseline vs. current migraine days
  • Continued medical necessity: Confirmation that alternative preventives remain ineffective or contraindicated
  • Tolerance: No significant adverse effects requiring discontinuation

Typical Renewal Timeline

  • Month 9-10: Begin gathering updated documentation
  • Month 11: Submit renewal PA request
  • Month 12: Approval should be in place before current authorization expires

Specialty Pharmacy Requirements

Why Emgality Requires Specialty Pharmacy

UnitedHealthcare classifies Emgality as a specialty medication requiring:

  • Special handling and storage
  • Patient education and injection training
  • Clinical monitoring and support
  • Home delivery logistics

Working with OptumRx Specialty Pharmacy

After PA Approval:

  1. Your prescription is automatically transferred to OptumRx Specialty
  2. OptumRx contacts you to set up delivery and payment
  3. First shipment includes injection training materials
  4. Ongoing refills are automatically scheduled

Patient Portal Access:

  • Track order status and delivery dates
  • Update shipping address and payment methods
  • Access clinical support and injection videos
  • Request refills and view prescription history

Troubleshooting Common Issues

Portal and System Problems

UHC Provider Portal Down:

  • Backup: Call UHC PA line at number on provider materials
  • Fax option may be available for urgent cases
  • Document all submission attempts with confirmation numbers

Missing PA Forms:

  • Download current forms from UHC Provider Portal
  • Use generic PA form if drug-specific form unavailable
  • Include all required clinical elements regardless of form used

Communication Breakdowns

Delayed Responses:

  • Follow up every 3-5 business days after submission
  • Request case reference numbers for all interactions
  • Escalate to UHC member services if provider portal issues persist

Missing Clinical Information:

  • UHC may request additional documentation
  • Respond within requested timeframe to avoid automatic denial
  • Submit more than requested rather than minimum requirements

FAQ

How long does UnitedHealthcare PA take in Pennsylvania? Standard PA decisions are made within 72 hours of complete submission. Urgent requests are decided within 24 hours when medical urgency is documented.

What if Emgality is non-formulary on my plan? You can request a formulary exception with strong clinical justification. This requires additional documentation showing medical necessity and may have higher cost-sharing.

Can I request an expedited appeal in Pennsylvania? Yes, both internal appeals and external reviews can be expedited if your doctor certifies that delay may seriously jeopardize your health. Expedited external reviews are decided within 72 hours.

Does step therapy apply if I failed preventives outside Pennsylvania? Yes, UnitedHealthcare accepts documented treatment failures from any location. Ensure you have complete records including dates, doses, and reasons for discontinuation.

What happens if I move during the appeals process? Pennsylvania external review rights apply to policies regulated by Pennsylvania. If you move, check whether your new state has similar protections or if federal external review applies.

Can I use manufacturer copay assistance with UnitedHealthcare? Yes, if you have commercial (non-government) insurance coverage. The Emgality savings program can reduce your copay to as low as $35 per month through 12/31/2025.

About Counterforce Health

Counterforce Health helps patients, clinicians, and specialty pharmacies get prescription drugs approved by turning insurance denials into targeted, evidence-backed appeals. The platform ingests denial letters, plan policies, and clinical notes, then identifies the denial basis and drafts point-by-point rebuttals aligned to the plan's own rules, pulling the right citations and clinical facts to build compelling cases.

Sources and Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on your specific plan documents and clinical circumstances. Always consult with your healthcare provider about appropriate treatment options and work with Counterforce Health or qualified advocates for complex appeals. For assistance with Pennsylvania insurance issues, contact the Pennsylvania Insurance Department at 1-877-881-6388.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.